The University of Tokyo · International Institute for Advanced Studies · 特任准教授

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan.
• Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses
• An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters.
• Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.

• Official profile